Plain-English translation of NCT07255729 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a new blood test that looks for tiny particles called exosomes in your blood to identify aggressive colon cancer before surgery. The test uses artificial intelligence to recognize patterns that show whether your cancer is likely to come back. This could help doctors decide whether you need chemotherapy before surgery to improve your chances of staying cancer-free.
Current imaging tests often miss aggressive colon cancers, which means some patients don't get chemotherapy before surgery when it could help them most. This new blood test aims to fill that gap by finding signs of aggressive cancer earlier, when treatment has the best chance of working.
You likely qualify if…
You likely don't qualify if…
If you qualify, researchers will use blood samples that were already taken before your surgery — you won't need additional blood draws for this study. The study is split into phases: first, researchers identify patterns in blood samples from patients with aggressive and non-aggressive cancers; then they build a computer model to recognize these patterns; finally, they test the model on a new group of patients to confirm it works. Your medical records and information about your cancer outcomes will be reviewed as part of the research.
AI-generated summary from trial data · Jul 11, 2026 · Not medical advice
United States